ANGELA MORRIS: Open Payments
NPI 1396268850 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 25 payments from 11 companies in 2025. Trend: 2023 $399 · 2024 $478 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $129 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $75 |
| MILLICENT US INC | 3 | $49 |
| Biogen, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Organon LLC | 2 | $26 |
| CooperSurgical, Inc. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Medtronic, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: Veozah, ZURZUVAE, Auvelity, FEMLYV, NEXPLANON, Paragard T 380A, ACCRUFER, INTRAROSA.
Industry payments across IN — which companies pay providers there.
